What's Happening?
Phillips Medisize, a company under Molex, is set to present strategies for scaling complex in vitro diagnostic (IVD) builds at the Association for Diagnostics & Laboratory Medicine (ADLM) 2026 Annual Meeting in Anaheim, California. The session, titled
'Designing for Scale through CDMO Collaboration: Lessons from Complex IVD Builds,' will be led by Pradnya Parulekar, Associate Director of Business Development at Phillips Medisize. The presentation will focus on the challenges faced by IVD innovators in scaling up manufacturing from early prototypes to high-volume production. The company emphasizes the importance of structured collaboration with contract development and manufacturing organizations (CDMOs) to mitigate risks associated with manufacturing automation and capital investment. Phillips Medisize aims to provide a blueprint for transitioning from early-stage concepts to commercial-scale production, highlighting the need for early engineering decisions that support scalability.
Why It's Important?
The presentation by Phillips Medisize is significant as it addresses the growing complexity and risks involved in scaling up the production of in vitro diagnostic devices. As the demand for advanced diagnostic tools increases, companies face challenges in automating and mass-producing these complex devices. The insights shared by Phillips Medisize could influence how diagnostic companies approach manufacturing, potentially leading to more efficient and cost-effective production processes. This is crucial for the healthcare industry, as it seeks to deliver innovative diagnostic solutions to a broader market. The strategies discussed could also impact the financial planning and operational strategies of companies involved in the development and manufacturing of medical devices.
What's Next?
Phillips Medisize's session at the ADLM 2026 Annual Meeting is scheduled for July 28, 2026, at 10 a.m. in Exhibit Hall Theater 2. Attendees will have the opportunity to learn about the practical applications of structured CDMO collaboration in scaling IVD projects. The company will also be available at booth 1376 in the Clinical Lab Expo, where further discussions and networking can take place. The outcomes of this presentation may lead to increased collaboration between diagnostic companies and CDMOs, potentially setting new industry standards for manufacturing scalability.
